2-(1,2,4-Oxadiazol-3-yl)propan-2-amine → 5-Chloro-6-cyclopropylmethoxy-pyridine-2-carboxylic acid (1-methyl-1-[1,2,4]oxadiazol-3-yl-ethyl)-amide
反応式
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:13]([OH:15])=O)=[N:6][C:7]=1[O:8][CH2:9][CH:10]1[CH2:12][CH2:11]1.[CH3:16][C:17]([NH2:24])([C:19]1[N:23]=[CH:22][O:21][N:20]=1)[CH3:18]>>[CH3:16][C:17]([NH:24][C:13]([C:5]1[CH:4]=[CH:3][C:2]([Cl:1])=[C:7]([O:8][CH2:9][CH:10]2[CH2:11][CH2:12]2)[N:6]=1)=[O:15])([C:19]1[N:23]=[CH:22][O:21][N:20]=1)[CH3:18]参加物
3
実験手順
The title compound was synthesized in analogy to Example 1, using 5-chloro-6-cyclopropylmethoxy-pyridine-2-carboxylic acid and 1-methyl-1-[1,2,4]oxadiazol-3-yl ethylamine (CAN 1153757-41-5) as starting materials, MS (LC/MS): m/e=337.1 [M+H]+.
出典と根拠
- ORDレコード
- ord-fed37a570ac34472a81ec9acc4b35681
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09321727B2
反応ノート
読み込み中…